Clinical trial NCT00580216: Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
Official title: A Multicenter, Randomized, Double-blind, Assessor-blind, Non-inferiority Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous Biotinylated Idraparinux (SSR126517E) With Oral Adjusted-dose Warfarin in the Prevention of Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
Study type: INTERVENTIONAL
Overall status: TERMINATED
Phase: PHASE3
Conditions: Atrial Fibrillation
Keywords: stroke
systemic thromboembolic events
Lead sponsor: Sanofi
Sponsor class: INDUSTRY
First posted: 2007-12-24
Enrollment: 3773
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: PREVENTION

Brief summary: The objective is to evaluate whether once weekly subcutaneous (SC) injection of idrabiotaparinux sodium (biotinylated idraparinux) is at least as efficient to prevent clots in brain and in the other organs than oral international normalized ratio (INR) adjusted-dose warfarin in patients with atrial fibrillation (AF).

Detailed description: The end of the study is defined by a common study end date for all participants, defined as 9 months (39 weeks) after the last participant randomized.

All participants will receive oral warfarin (or matching placebo) and weekly SC injections of idrabiotaparinux sodium (or matching placebo) up to 6 months before the common study end date. All participants are expected to be treated for at least 6 months.

All participants will have then an 6-month observational period after cessation of study treatment.

Eligibility criteria: Inclusion Criteria:

* Non valvular atrial fibrillation (AF)
* Indication for long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack (TIA) or systemic embolism and/or at least two of the following risk factors: hypertension requiring drug treatment, moderately or severely impaired left ventricular function and/or congestive heart failure, age \> or = 75 years, diabetes mellitus.

Main exclusion Criteria:

* Indication for VKA other than AF
* Stroke or TIA within previous 5 days
* Transient AF caused by a reversible disorder
* Planned major surgery/trauma or cardioversion within 30 days
* INR \> 3 at baseline
* Active bleeding or high risk of bleeding
* Uncontrolled hypertension
* Pregnancy or childbearing potential without proper contraceptive measures or breast feeding.

Primary outcomes:
measure: Composite of all fatal or non-fatal strokes or non central nervous system (CNS) systemic embolic events (SE)
timeFrame: From randomization up to the end of the treatment period (minimum of 6 months)
Secondary outcomes:
measure: Components of the primary study outcome measure:
timeFrame: From randomization up to the end of the treatment period (minimum of 6 months)
measure: Composite of stroke or non CNS SE or myocardial infarction (MI) or venous thromboembolism (VTE) or major bleeding or death
timeFrame: From randomization up to the end of the treatment period (minimum of 6 months)
Other outcomes:
Locations:
city: Mobile
country: United States
facility: Sanofi-Aventis Investigational Site Number 840227
state: Alabama
city: Tucson
country: United States
facility: Sanofi-Aventis Investigational Site Number 840209
state: Arizona
city: Little Rock
country: United States
facility: Sanofi-Aventis Investigational Site Number 840255
state: Arkansas
city: Little Rock
country: United States
facility: Sanofi-Aventis Investigational Site Number 840224
state: Arkansas
city: Mountain Home
country: United States
facility: Sanofi-Aventis Investigational Site Number 840179
state: Arkansas
city: Beverly Hills
country: United States
facility: Sanofi-Aventis Investigational Site Number 840270
state: California
city: Beverly Hills
country: United States
facility: Sanofi-Aventis Investigational Site Number 840278
state: California
city: Burbank
country: United States
facility: Sanofi-Aventis Investigational Site Number 840241
state: California
city: Corona
country: United States
facility: Sanofi-Aventis Investigational Site Number 840010
state: California
city: Encino
country: United States
facility: Sanofi-Aventis Investigational Site Number 840195
state: California
city: Loma Linda
country: United States
facility: Sanofi-Aventis Investigational Site Number 840033
state: California
city: Long Beach
country: United States
facility: Sanofi-Aventis Investigational Site Number 840184
state: California
city: Los Banos
country: United States
facility: Sanofi-Aventis Investigational Site Number 840183
state: California
city: Northridge
country: United States
facility: Sanofi-Aventis Investigational Site Number 840272
state: California
city: Orange
country: United States
facility: Sanofi-Aventis Investigational Site Number 840213
state: California
city: Redondo Beach
country: United States
facility: Sanofi-Aventis Investigational Site Number 840009
state: California
city: Riverside
country: United States
facility: Sanofi-Aventis Investigational Site Number 840298
state: California
city: San Diego
country: United States
facility: Sanofi-Aventis Investigational Site Number 840264
state: California
city: San Diego
country: United States
facility: Sanofi-Aventis Investigational Site Number 840275
state: California
city: Santa Ana
country: United States
facility: Sanofi-Aventis Investigational Site Number 840103
state: California
city: Santa Rosa
country: United States
facility: Sanofi-Aventis Investigational Site Number 840002
state: California
city: Torrance
country: United States
facility: Sanofi-Aventis Investigational Site Number 840111
state: California
city: Visalia
country: United States
facility: Sanofi-Aventis Investigational Site Number 840118
state: California
city: Bridgeport
country: United States
facility: Sanofi-Aventis Investigational Site Number 840268
state: Connecticut
city: Bay Pines
country: United States
facility: Sanofi-Aventis Investigational Site Number 840246
state: Florida
city: Beach
country: United States
facility: Sanofi-Aventis Investigational Site Number 840066
state: Florida
city: Brandon
country: United States
facility: Sanofi-Aventis Investigational Site Number 840313
state: Florida
city: Dunnellon
country: United States
facility: Sanofi-Aventis Investigational Site Number 840084
state: Florida
city: Fort Lauderdale
country: United States
facility: Sanofi-Aventis Investigational Site Number 840220
state: Florida
city: Ft. Lauderdale
country: United States
facility: Sanofi-Aventis Investigational Site Number 840138
state: Florida
city: Gainesville
country: United States
facility: Sanofi-Aventis Investigational Site Number 840215
state: Florida
city: Hollywood
country: United States
facility: Sanofi-Aventis Investigational Site Number 840131
state: Florida
city: Hollywood
country: United States
facility: Sanofi-Aventis Investigational Site Number 840161
state: Florida
city: Key West
country: United States
facility: Sanofi-Aventis Investigational Site Number 840234
state: Florida
city: Lake Mary
country: United States
facility: Sanofi-Aventis Investigational Site Number 840112
state: Florida
city: Lakeland
country: United States
facility: Sanofi-Aventis Investigational Site Number 840053
state: Florida
city: Melbourne
country: United States
facility: Sanofi-Aventis Investigational Site Number 840198
state: Florida
city: Miami
country: United States
facility: Sanofi-Aventis Investigational Site Number 840117
state: Florida
city: Niceville
country: United States
facility: Sanofi-Aventis Investigational Site Number 840003
state: Florida
city: Ocala
country: United States
facility: Sanofi-Aventis Investigational Site Number 840230
state: Florida
city: Orlando
country: United States
facility: Sanofi-Aventis Investigational Site Number 840202
state: Florida
city: Orlando
country: United States
facility: Sanofi-Aventis Investigational Site Number 840306
state: Florida
city: Ormond Beach
country: United States
facility: Sanofi-Aventis Investigational Site Number 840022
state: Florida
city: Palm Harbor
country: United States
facility: Sanofi-Aventis Investigational Site Number 840110
state: Florida
city: Plantation
country: United States
facility: Sanofi-Aventis Investigational Site Number 840211
state: Florida
city: Sanford
country: United States
facility: Sanofi-Aventis Investigational Site Number 840116
state: Florida
city: Spring Hill
country: United States
facility: Sanofi-Aventis Investigational Site Number 840243
state: Florida
city: St. Petersburg
country: United States
facility: Sanofi-Aventis Investigational Site Number 840082
state: Florida
city: St. Petersburg
country: United States
facility: Sanofi-Aventis Investigational Site Number 840012
state: Florida
city: Atlanta
country: United States
facility: Sanofi-Aventis Investigational Site Number 840073
state: Georgia
city: Augusta
country: United States
facility: Sanofi-Aventis Investigational Site Number 840273
state: Georgia
city: Columbus
country: United States
facility: Sanofi-Aventis Investigational Site Number 840204
state: Georgia
city: Columbus
country: United States
facility: Sanofi-Aventis Investigational Site Number 840290
state: Georgia
city: Columbus
country: United States
facility: Sanofi-Aventis Investigational Site Number 840225
state: Georgia
city: Dunwoody
country: United States
facility: Sanofi-Aventis Investigational Site Number 840305
state: Georgia
city: Savannah
country: United States
facility: Sanofi-Aventis Investigational Site Number 840165
state: Georgia
city: Idaho Falls
country: United States
facility: Sanofi-Aventis Investigational Site Number 840130
state: Idaho
city: Idaho Falls
country: United States
facility: Sanofi-Aventis Investigational Site Number 840228
state: Idaho
city: Nampa
country: United States
facility: Sanofi-Aventis Investigational Site Number 840143
state: Idaho
city: Chicago
country: United States
facility: Sanofi-Aventis Investigational Site Number 840221
state: Illinois
city: Chicago
country: United States
facility: Sanofi-Aventis Investigational Site Number 840206
state: Illinois
city: Beaver
country: United States
facility: Sanofi-Aventis Investigational Site Number 840280
state: Indiana
city: Elkhart
country: United States
facility: Sanofi-Aventis Investigational Site Number 840014
state: Indiana
city: Wichita
country: United States
facility: Sanofi-Aventis Investigational Site Number 840249
state: Kansas
city: Lexington
country: United States
facility: Sanofi-Aventis Investigational Site Number 840265
state: Kentucky
city: Alexandria
country: United States
facility: Sanofi-Aventis Investigational Site Number 840047
state: Louisiana
city: Jena
country: United States
facility: Sanofi-Aventis Investigational Site Number 840218
state: Louisiana
city: Lafayette
country: United States
facility: Sanofi-Aventis Investigational Site Number 840247
state: Louisiana
city: Lake Charles
country: United States
facility: Sanofi-Aventis Investigational Site Number 840158
state: Louisiana
city: Natchitoches
country: United States
facility: Sanofi-Aventis Investigational Site Number 840077
state: Louisiana
city: Shreveport
country: United States
facility: Sanofi-Aventis Investigational Site Number 840259
state: Louisiana
city: Shreveport
country: United States
facility: Sanofi-Aventis Investigational Site Number 840231
state: Louisiana
city: Shreveport
country: United States
facility: Sanofi-Aventis Investigational Site Number 840232
state: Louisiana
city: Auburn
country: United States
facility: Sanofi-Aventis Investigational Site Number 840145
state: Maine
city: Baltimore
country: United States
facility: Sanofi-Aventis Investigational Site Number 840017
state: Maryland
city: Denton
country: United States
facility: Sanofi-Aventis Investigational Site Number 840317
state: Maryland
city: Alpena
country: United States
facility: Sanofi-Aventis Investigational Site Number 840311
state: Michigan
city: Brighton
country: United States
facility: Sanofi-Aventis Investigational Site Number 840276
state: Michigan
city: Detroit
country: United States
facility: Sanofi-Aventis Investigational Site Number 840242
state: Michigan
city: Grand Rapids
country: United States
facility: Sanofi-Aventis Investigational Site Number 840253
state: Michigan
city: St. Clair Shores
country: United States
facility: Sanofi-Aventis Investigational Site Number 840137
state: Michigan
city: St Cloud
country: United States
facility: Sanofi-Aventis Investigational Site Number 840134
state: Minnesota
city: Gulfport
country: United States
facility: Sanofi-Aventis Investigational Site Number 840067
state: Mississippi
city: Picayune
country: United States
facility: Sanofi-Aventis Investigational Site Number 840006
state: Mississippi
city: St Louis
country: United States
facility: Sanofi-Aventis Investigational Site Number 840201
state: Missouri
city: St. Louis
country: United States
facility: Sanofi-Aventis Investigational Site Number 840310
state: Missouri
city: St. Louis
country: United States
facility: Sanofi-Aventis Investigational Site Number 840200
state: Missouri
city: St. Louis
country: United States
facility: Sanofi-Aventis Investigational Site Number 840323
state: Missouri
city: Anaconda
country: United States
facility: Sanofi-Aventis Investigational Site Number 840096
state: Montana
city: Butte
country: United States
facility: Sanofi-Aventis Investigational Site Number 840008
state: Montana
city: Fremont
country: United States
facility: Sanofi-Aventis Investigational Site Number 840126
state: Nebraska
city: Las Vegas
country: United States
facility: Sanofi-Aventis Investigational Site Number 840051
state: Nevada
city: Las Vegas
country: United States
facility: Sanofi-Aventis Investigational Site Number 840258
state: Nevada
city: Hamilton
country: United States
facility: Sanofi-Aventis Investigational Site Number 840303
state: New Jersey
city: Linden
country: United States
facility: Sanofi-Aventis Investigational Site Number 840109
state: New Jersey
city: Morristown
country: United States
facility: Sanofi-Aventis Investigational Site Number 840024
state: New Jersey
city: Bronx
country: United States
facility: Sanofi-Aventis Investigational Site Number 840284
state: New York
city: Buffalo
country: United States
facility: Sanofi-Aventis Investigational Site Number 840102
state: New York
city: Johnson City
country: United States
facility: Sanofi-Aventis Investigational Site Number 840152
state: New York
city: Rochester
country: United States
facility: Sanofi-Aventis Investigational Site Number 840159
state: New York
city: Westfield
country: United States
facility: Sanofi-Aventis Investigational Site Number 840056
state: New York
city: Greensboro
country: United States
facility: Sanofi-Aventis Investigational Site Number 840277
state: North Carolina
city: Greensboro
country: United States
facility: Sanofi-Aventis Investigational Site Number 840196
state: North Carolina
city: Hickory
country: United States
facility: Sanofi-Aventis Investigational Site Number 840127
state: North Carolina
city: Raleigh
country: United States
facility: Sanofi-Aventis Investigational Site Number 840150
state: North Carolina
city: Rocky Mount
country: United States
facility: Sanofi-Aventis Investigational Site Number 840185
state: North Carolina
city: Fargo
country: United States
facility: Sanofi-Aventis Investigational Site Number 840020
state: North Dakota
city: Centerville
country: United States
facility: Sanofi-Aventis Investigational Site Number 840197
state: Ohio
city: Cincinnati
country: United States
facility: Sanofi-Aventis Investigational Site Number 840074
state: Ohio
city: Cleveland
country: United States
facility: Sanofi-Aventis Investigational Site Number 840146
state: Ohio
city: Gallipolis
country: United States
facility: Sanofi-Aventis Investigational Site Number 840292
state: Ohio
city: Mason
country: United States
facility: Sanofi-Aventis Investigational Site Number 840026
state: Ohio
city: Toledo
country: United States
facility: Sanofi-Aventis Investigational Site Number 840233
state: Ohio
city: Wadsworth
country: United States
facility: Sanofi-Aventis Investigational Site Number 840064
state: Ohio
city: Oklahoma City
country: United States
facility: Sanofi-Aventis Investigational Site Number 840045
state: Oklahoma
city: Tulsa
country: United States
facility: Sanofi-Aventis Investigational Site Number 840133
state: Oklahoma
city: Bend
country: United States
facility: Sanofi-Aventis Investigational Site Number 840113
state: Oregon
city: Portland
country: United States
facility: Sanofi-Aventis Investigational Site Number 840257
state: Oregon
city: Indiana
country: United States
facility: Sanofi-Aventis Investigational Site Number 840304
state: Pennsylvania
city: Philadelphia
country: United States
facility: Sanofi-Aventis Investigational Site Number 840128
state: Pennsylvania
city: Philadelphia
country: United States
facility: Sanofi-Aventis Investigational Site Number 840160
state: Pennsylvania
city: Philadelphia
country: United States
facility: Sanofi-Aventis Investigational Site Number 840339
state: Pennsylvania
city: Pittsburgh
country: United States
facility: Sanofi-Aventis Investigational Site Number 840181
state: Pennsylvania
city: Scotland
country: United States
facility: Sanofi-Aventis Investigational Site Number 840229
state: Pennsylvania
city: Stoneboro
country: United States
facility: Sanofi-Aventis Investigational Site Number 840072
state: Pennsylvania
city: Cranston
country: United States
facility: Sanofi-Aventis Investigational Site Number 840248
state: Rhode Island
city: Anderson
country: United States
facility: Sanofi-Aventis Investigational Site Number 840261
state: South Carolina
city: Anderson
country: United States
facility: Sanofi-Aventis Investigational Site Number 840297
state: South Carolina
city: Camden
country: United States
facility: Sanofi-Aventis Investigational Site Number 840172
state: South Carolina
city: Columbia
country: United States
facility: Sanofi-Aventis Investigational Site Number 840168
state: South Carolina
city: Manning
country: United States
facility: Sanofi-Aventis Investigational Site Number 840122
state: South Carolina
city: Newberry
country: United States
facility: Sanofi-Aventis Investigational Site Number 840085
state: South Carolina
city: Pelzer
country: United States
facility: Sanofi-Aventis Investigational Site Number 840189
state: South Carolina
city: Fort Meade
country: United States
facility: Sanofi-Aventis Investigational Site Number 840032
state: South Dakota
city: Athens
country: United States
facility: Sanofi-Aventis Investigational Site Number 840062
state: Tennessee
city: Bristol
country: United States
facility: Sanofi-Aventis Investigational Site Number 840048
state: Tennessee
city: Bristol
country: United States
facility: Sanofi-Aventis Investigational Site Number 840052
state: Tennessee
city: Cleveland
country: United States
facility: Sanofi-Aventis Investigational Site Number 840104
state: Tennessee
city: Johnson City
country: United States
facility: Sanofi-Aventis Investigational Site Number 840129
state: Tennessee
city: Nashville
country: United States
facility: Sanofi-Aventis Investigational Site Number 840269
state: Tennessee
city: Amarillo
country: United States
facility: Sanofi-Aventis Investigational Site Number 840076
state: Texas
city: Corsicana
country: United States
facility: Sanofi-Aventis Investigational Site Number 840252
state: Texas
city: Houston
country: United States
facility: Sanofi-Aventis Investigational Site Number 840286
state: Texas
city: Irving
country: United States
facility: Sanofi-Aventis Investigational Site Number 840132
state: Texas
city: Odessa
country: United States
facility: Sanofi-Aventis Investigational Site Number 840005
state: Texas
city: Odessa
country: United States
facility: Sanofi-Aventis Investigational Site Number 840289
state: Texas
city: San Antonio
country: United States
facility: Sanofi-Aventis Investigational Site Number 840186
state: Texas
city: San Antonio
country: United States
facility: Sanofi-Aventis Investigational Site Number 840194
state: Texas
city: Temple
country: United States
facility: Sanofi-Aventis Investigational Site Number 840236
state: Texas
city: Victoria
country: United States
facility: Sanofi-Aventis Investigational Site Number 840011
state: Texas
city: Wichita Falls
country: United States
facility: Sanofi-Aventis Investigational Site Number 840285
state: Texas
city: Clinton
country: United States
facility: Sanofi-Aventis Investigational Site Number 840223
state: Utah
city: Salt Lake City
country: United States
facility: Sanofi-Aventis Investigational Site Number 840238
state: Utah
city: Salt Lake City
country: United States
facility: Sanofi-Aventis Investigational Site Number 840308
state: Utah
city: Salem
country: United States
facility: Sanofi-Aventis Investigational Site Number 840068
state: Virginia
city: Springfield
country: United States
facility: Sanofi-Aventis Investigational Site Number 840219
state: Virginia
city: Everett
country: United States
facility: Sanofi-Aventis Investigational Site Number 840058
state: Washington
city: Seattle
country: United States
facility: Sanofi-Aventis Investigational Site Number 840123
state: Washington
city: Tacoma
country: United States
facility: Sanofi-Aventis Investigational Site Number 840019
state: Washington
city: Beloit
country: United States
facility: Sanofi-Aventis Investigational Site Number 840256
state: Wisconsin
city: Madison
country: United States
facility: Sanofi-Aventis Investigational Site Number 840293
state: Wisconsin
city: Wauwatosa
country: United States
facility: Sanofi-Aventis Investigational Site Number 840282
state: Wisconsin
city: Buenos Aires
country: Argentina
facility: Sanofi-Aventis Investigational Site Number 032007
city: Buenos Aires
country: Argentina
facility: Sanofi-Aventis Investigational Site Number 032011
city: Buenos Aires
country: Argentina
facility: Sanofi-Aventis Investigational Site Number 032001
city: Buenos Aires
country: Argentina
facility: Sanofi-Aventis Investigational Site Number 032005
city: Capital Federal
country: Argentina
facility: Sanofi-Aventis Investigational Site Number 032009
city: Corrientes
country: Argentina
facility: Sanofi-Aventis Investigational Site Number 032012
city: Mar Del Plata
country: Argentina
facility: Sanofi-Aventis Investigational Site Number 032006
city: Moron
country: Argentina
facility: Sanofi-Aventis Investigational Site Number 032014
city: Salta
country: Argentina
facility: Sanofi-Aventis Investigational Site Number 032016
city: Zarate
country: Argentina
facility: Sanofi-Aventis Investigational Site Number 032010
city: Adelaide
country: Australia
facility: Sanofi-Aventis Investigational Site Number 036006
city: Auchenflower
country: Australia
facility: Sanofi-Aventis Investigational Site Number 036003
city: Box Hill
country: Australia
facility: Sanofi-Aventis Investigational Site Number 036008
city: Coffs Harbour
country: Australia
facility: Sanofi-Aventis Investigational Site Number 036005
city: Kippa Ring
country: Australia
facility: Sanofi-Aventis Investigational Site Number 036001
city: Kippa Ring
country: Australia
facility: Sanofi-Aventis Investigational Site Number 036002
city: Launceston
country: Australia
facility: Sanofi-Aventis Investigational Site Number 036009
city: Woden
country: Australia
facility: Sanofi-Aventis Investigational Site Number 036010
city: Graz
country: Austria
facility: Sanofi-Aventis Investigational Site Number 040001
city: Linz
country: Austria
facility: Sanofi-Aventis Investigational Site Number 040004
city: Minsk
country: Belarus
facility: Sanofi-Aventis Investigational Site Number 112001
city: Minsk
country: Belarus
facility: Sanofi-Aventis Investigational Site Number 112002
city: Minsk
country: Belarus
facility: Sanofi-Aventis Investigational Site Number 112003
city: Minsk
country: Belarus
facility: Sanofi-Aventis Investigational Site Number 112005
city: Belo Horizonte
country: Brazil
facility: Sanofi-Aventis Investigational Site Number 076019
city: Campina Grande Do Sul
country: Brazil
facility: Sanofi-Aventis Investigational Site Number 076011
city: Campinas
country: Brazil
facility: Sanofi-Aventis Investigational Site Number 076007
city: Campinas
country: Brazil
facility: Sanofi-Aventis Investigational Site Number 076013
city: Curitiba
country: Brazil
facility: Sanofi-Aventis Investigational Site Number 076001
city: Goiania
country: Brazil
facility: Sanofi-Aventis Investigational Site Number 076017
city: Goiania
country: Brazil
facility: Sanofi-Aventis Investigational Site Number 076016
city: Maceio
country: Brazil
facility: Sanofi-Aventis Investigational Site Number 076018
city: Porto Alegre
country: Brazil
facility: Sanofi-Aventis Investigational Site Number 076012
city: Porto Alegre
country: Brazil
facility: Sanofi-Aventis Investigational Site Number 076008
city: Porto Alegre
country: Brazil
facility: Sanofi-Aventis Investigational Site Number 076014
city: Recife
country: Brazil
facility: Sanofi-Aventis Investigational Site Number 076009
city: Sao Jose Do Rio Preto
country: Brazil
facility: Sanofi-Aventis Investigational Site Number 076005
city: Sao Paulo
country: Brazil
facility: Sanofi-Aventis Investigational Site Number 076010
city: Uberlandia
country: Brazil
facility: Sanofi-Aventis Investigational Site Number 076015
city: Pleven
country: Bulgaria
facility: Sanofi-Aventis Investigational Site Number 100004
city: Plovdiv
country: Bulgaria
facility: Sanofi-Aventis Investigational Site Number 100005
city: Sofia
country: Bulgaria
facility: Sanofi-Aventis Investigational Site Number 100001
city: Sofia
country: Bulgaria
facility: Sanofi-Aventis Investigational Site Number 100002
city: Sofia
country: Bulgaria
facility: Sanofi-Aventis Investigational Site Number 100003
city: London
country: Canada
facility: Sanofi-Aventis Investigational Site Number 124014
city: Newmarket
country: Canada
facility: Sanofi-Aventis Investigational Site Number 124006
city: Quebec
country: Canada
facility: Sanofi-Aventis Investigational Site Number 124012
city: Toronto
country: Canada
facility: Sanofi-Aventis Investigational Site Number 124011
city: Santiago
country: Chile
facility: Sanofi-Aventis Investigational Site Number 152007
city: Santiago
country: Chile
facility: Sanofi-Aventis Investigational Site Number 152001
city: Santiago
country: Chile
facility: Sanofi-Aventis Investigational Site Number 152003
city: Santiago
country: Chile
facility: Sanofi-Aventis Investigational Site Number 152004
city: Santiago
country: Chile
facility: Sanofi-Aventis Investigational Site Number 152005
city: Santiago
country: Chile
facility: Sanofi-Aventis Investigational Site Number 152008
city: Viña Del Mar
country: Chile
facility: Sanofi-Aventis Investigational Site Number 152009
city: Viña Del Mar
country: Chile
facility: Sanofi-Aventis Investigational Site Number 152006
city: Bogota
country: Colombia
facility: Sanofi-Aventis Investigational Site Number 170003
city: Bogota
country: Colombia
facility: Sanofi-Aventis Investigational Site Number 170006
city: Bucaramanga
country: Colombia
facility: Sanofi-Aventis Investigational Site Number 170001
city: Envigado-Antioquia
country: Colombia
facility: Sanofi-Aventis Investigational Site Number 170005
city: Medellin
country: Colombia
facility: Sanofi-Aventis Investigational Site Number 170002
city: San José
country: Costa Rica
facility: Sanofi-Aventis Investigational Site Number 188004
city: Split
country: Croatia
facility: Sanofi-Aventis Investigational Site Number 191003
city: Zagreb
country: Croatia
facility: Sanofi-Aventis Investigational Site Number 191001
city: Zagreb
country: Croatia
facility: Sanofi-Aventis Investigational Site Number 191004
city: Chomutov
country: Czech Republic
facility: Sanofi-Aventis Investigational Site Number 203005
city: Jihlava
country: Czech Republic
facility: Sanofi-Aventis Investigational Site Number 203003
city: Ostrava Vitkovice
country: Czech Republic
facility: Sanofi-Aventis Investigational Site Number 203009
city: Pardubice
country: Czech Republic
facility: Sanofi-Aventis Investigational Site Number 203001
city: Plzen - Bory
country: Czech Republic
facility: Sanofi-Aventis Investigational Site Number 203011
city: Praha 2
country: Czech Republic
facility: Sanofi-Aventis Investigational Site Number 203002
city: Praha 4
country: Czech Republic
facility: Sanofi-Aventis Investigational Site Number 203004
city: Praha 6
country: Czech Republic
facility: Sanofi-Aventis Investigational Site Number 203010
city: Prostejov
country: Czech Republic
facility: Sanofi-Aventis Investigational Site Number 203006
city: Usti Nad Orlici
country: Czech Republic
facility: Sanofi-Aventis Investigational Site Number 203008
city: Glostrup
country: Denmark
facility: Sanofi-Aventis Investigational Site Number 208002
city: Hellerup
country: Denmark
facility: Sanofi-Aventis Investigational Site Number 208001
city: Hvidovre
country: Denmark
facility: Sanofi-Aventis Investigational Site Number 208007
city: København S
country: Denmark
facility: Sanofi-Aventis Investigational Site Number 208003
city: Odense
country: Denmark
facility: Sanofi-Aventis Investigational Site Number 208004
city: Roskilde
country: Denmark
facility: Sanofi-Aventis Investigational Site Number 208006
city: Svendborg
country: Denmark
facility: Sanofi-Aventis Investigational Site Number 208005
city: Alexandria
country: Egypt
facility: Sanofi-Aventis Investigational Site Number 818002
city: Alexandria
country: Egypt
facility: Sanofi-Aventis Investigational Site Number 818003
city: Alexandria
country: Egypt
facility: Sanofi-Aventis Investigational Site Number 818004
city: Cairo
country: Egypt
facility: Sanofi-Aventis Investigational Site Number 818001
city: Tallinn
country: Estonia
facility: Sanofi-Aventis Investigational Site Number 233003
city: Tallinn
country: Estonia
facility: Sanofi-Aventis Investigational Site Number 233004
city: Tallinn
country: Estonia
facility: Sanofi-Aventis Investigational Site Number 233001
city: Tartu
country: Estonia
facility: Sanofi-Aventis Investigational Site Number 233002
city: Helsinki
country: Finland
facility: Sanofi-Aventis Investigational Site Number 246001
city: Abbeville
country: France
facility: Sanofi-Aventis Investigational Site Number 250028
city: Albi Cedex 9
country: France
facility: Sanofi-Aventis Investigational Site Number 250012
city: Allauch
country: France
facility: Sanofi-Aventis Investigational Site Number 250034
city: Belfort Cedex
country: France
facility: Sanofi-Aventis Investigational Site Number 250031
city: Bordeaux
country: France
facility: Sanofi-Aventis Investigational Site Number 250011
city: Brest Cedex 2
country: France
facility: Sanofi-Aventis Investigational Site Number 250010
city: Brest
country: France
facility: Sanofi-Aventis Investigational Site Number 250021
city: Bron
country: France
facility: Sanofi-Aventis Investigational Site Number 250035
city: Cholet Cedex
country: France
facility: Sanofi-Aventis Investigational Site Number 250022
city: Dijon Cedex
country: France
facility: Sanofi-Aventis Investigational Site Number 250018
city: Dijon
country: France
facility: Sanofi-Aventis Investigational Site Number 250006
city: La Rochelle
country: France
facility: Sanofi-Aventis Investigational Site Number 250004
city: Le Chesnay Cedex
country: France
facility: Sanofi-Aventis Investigational Site Number 250029
city: Lille
country: France
facility: Sanofi-Aventis Investigational Site Number 250019
city: Lille
country: France
facility: Sanofi-Aventis Investigational Site Number 250015
city: Metz Tessy
country: France
facility: Sanofi-Aventis Investigational Site Number 250030
city: Montpellier
country: France
facility: Sanofi-Aventis Investigational Site Number 250003
city: Montpellier
country: France
facility: Sanofi-Aventis Investigational Site Number 250032
city: Nice Cedex
country: France
facility: Sanofi-Aventis Investigational Site Number 250016
city: Paris Cedex 13
country: France
facility: Sanofi-Aventis Investigational Site Number 250014
city: Paris Cedex 14
country: France
facility: Sanofi-Aventis Investigational Site Number 250008
city: Paris
country: France
facility: Sanofi-Aventis Investigational Site Number 250001
city: Saint Etienne Cedex 2
country: France
facility: Sanofi-Aventis Investigational Site Number 250005
city: Toulouse Cedex 9
country: France
facility: Sanofi-Aventis Investigational Site Number 250026
city: Tours Cedex 1
country: France
facility: Sanofi-Aventis Investigational Site Number 250027
city: Vandoeuvre Les Nancy Cedex
country: France
facility: Sanofi-Aventis Investigational Site Number 250002
city: Athens
country: Greece
facility: Sanofi-Aventis Investigational Site Number 300009
city: Athens
country: Greece
facility: Sanofi-Aventis Investigational Site Number 300007
city: Athens
country: Greece
facility: Sanofi-Aventis Investigational Site Number 300002
city: Athens
country: Greece
facility: Sanofi-Aventis Investigational Site Number 300005
city: Chalkida
country: Greece
facility: Sanofi-Aventis Investigational Site Number 300006
city: Chios
country: Greece
facility: Sanofi-Aventis Investigational Site Number 300004
city: Elefsina
country: Greece
facility: Sanofi-Aventis Investigational Site Number 300008
city: Guatemala
country: Guatemala
facility: Sanofi-Aventis Investigational Site Number 320002
city: Guatemala
country: Guatemala
facility: Sanofi-Aventis Investigational Site Number 320001
city: Guatemala
country: Guatemala
facility: Sanofi-Aventis Investigational Site Number 320003
city: Guatemala
country: Guatemala
facility: Sanofi-Aventis Investigational Site Number 320004
city: Ahmedabad
country: India
facility: Sanofi-Aventis Investigational Site Number 356001
city: Ahmedabad
country: India
facility: Sanofi-Aventis Investigational Site Number 356010
city: Bangalore
country: India
facility: Sanofi-Aventis Investigational Site Number 356015
city: Bangalore
country: India
facility: Sanofi-Aventis Investigational Site Number 356009
city: Chennai
country: India
facility: Sanofi-Aventis Investigational Site Number 356005
city: Coimbatore
country: India
facility: Sanofi-Aventis Investigational Site Number 356002
city: Coimbatore
country: India
facility: Sanofi-Aventis Investigational Site Number 356007
city: Lucknow
country: India
facility: Sanofi-Aventis Investigational Site Number 356013
city: Lucknow
country: India
facility: Sanofi-Aventis Investigational Site Number 356006
city: Mumbai
country: India
facility: Sanofi-Aventis Investigational Site Number 356017
city: Mysore
country: India
facility: Sanofi-Aventis Investigational Site Number 356014
city: Nashik
country: India
facility: Sanofi-Aventis Investigational Site Number 356020
city: New Delhi
country: India
facility: Sanofi-Aventis Investigational Site Number 356004
city: New Delhi
country: India
facility: Sanofi-Aventis Investigational Site Number 356012
city: Pune.
country: India
facility: Sanofi-Aventis Investigational Site Number 356018
city: Pune
country: India
facility: Sanofi-Aventis Investigational Site Number 356011
city: Secunderabad
country: India
facility: Sanofi-Aventis Investigational Site Number 356003
city: Jakarta
country: Indonesia
facility: Sanofi-Aventis Investigational Site Number 360002
city: Jakarta
country: Indonesia
facility: Sanofi-Aventis Investigational Site Number 360001
city: Afula
country: Israel
facility: Sanofi-Aventis Investigational Site Number 376003
city: Ashkelon
country: Israel
facility: Sanofi-Aventis Investigational Site Number 376015
city: Givatayim
country: Israel
facility: Sanofi-Aventis Investigational Site Number 376001
city: Haifa
country: Israel
facility: Sanofi-Aventis Investigational Site Number 376007
city: Haifa
country: Israel
facility: Sanofi-Aventis Investigational Site Number 376014
city: Holon
country: Israel
facility: Sanofi-Aventis Investigational Site Number 376004
city: Nahariya
country: Israel
facility: Sanofi-Aventis Investigational Site Number 376012
city: Nazareth
country: Israel
facility: Sanofi-Aventis Investigational Site Number 376009
city: Rehovot
country: Israel
facility: Sanofi-Aventis Investigational Site Number 376011
city: Tel Aviv
country: Israel
facility: Sanofi-Aventis Investigational Site Number 376002
city: Ascoli Piceno
country: Italy
facility: Sanofi-Aventis Investigational Site Number 380015
city: Borgo San Lorenzo
country: Italy
facility: Sanofi-Aventis Investigational Site Number 380018
city: Chieti
country: Italy
facility: Sanofi-Aventis Investigational Site Number 380016
city: Fidenza
country: Italy
facility: Sanofi-Aventis Investigational Site Number 380005
city: Merate
country: Italy
facility: Sanofi-Aventis Investigational Site Number 380010
city: Milano
country: Italy
facility: Sanofi-Aventis Investigational Site Number 380014
city: Novara
country: Italy
facility: Sanofi-Aventis Investigational Site Number 380020
city: Padova
country: Italy
facility: Sanofi-Aventis Investigational Site Number 380001
city: Padova
country: Italy
facility: Sanofi-Aventis Investigational Site Number 380007
city: Palermo
country: Italy
facility: Sanofi-Aventis Investigational Site Number 380004
city: Pavia
country: Italy
facility: Sanofi-Aventis Investigational Site Number 380008
city: Perugia
country: Italy
facility: Sanofi-Aventis Investigational Site Number 380021
city: San Daniele Del Friuli
country: Italy
facility: Sanofi-Aventis Investigational Site Number 380013
city: Sassari
country: Italy
facility: Sanofi-Aventis Investigational Site Number 380003
city: Torino
country: Italy
facility: Sanofi-Aventis Investigational Site Number 380011
city: Treviso
country: Italy
facility: Sanofi-Aventis Investigational Site Number 380009
city: Anyang
country: Korea, Republic of
facility: Sanofi-Aventis Investigational Site Number 410008
city: Daegu
country: Korea, Republic of
facility: Sanofi-Aventis Investigational Site Number 410002
city: Goyang
country: Korea, Republic of
facility: Sanofi-Aventis Investigational Site Number 410006
city: Goyang
country: Korea, Republic of
facility: Sanofi-Aventis Investigational Site Number 410012
city: Gwangju
country: Korea, Republic of
facility: Sanofi-Aventis Investigational Site Number 410007
city: Seongnam
country: Korea, Republic of
facility: Sanofi-Aventis Investigational Site Number 410003
city: Seoul
country: Korea, Republic of
facility: Sanofi-Aventis Investigational Site Number 410001
city: Seoul
country: Korea, Republic of
facility: Sanofi-Aventis Investigational Site Number 410004
city: Seoul
country: Korea, Republic of
facility: Sanofi-Aventis Investigational Site Number 410005
city: Seoul
country: Korea, Republic of
facility: Sanofi-Aventis Investigational Site Number 410011
city: Kaunas
country: Lithuania
facility: Sanofi-Aventis Investigational Site Number 440004
city: Kaunas
country: Lithuania
facility: Sanofi-Aventis Investigational Site Number 440002
city: Vilnius
country: Lithuania
facility: Sanofi-Aventis Investigational Site Number 440003
city: Vilnius
country: Lithuania
facility: Sanofi-Aventis Investigational Site Number 440001
city: Kuching
country: Malaysia
facility: Sanofi-Aventis Investigational Site Number 458001
city: Penang
country: Malaysia
facility: Sanofi-Aventis Investigational Site Number 458002
city: Taiping
country: Malaysia
facility: Sanofi-Aventis Investigational Site Number 458005
city: Acapulco
country: Mexico
facility: Sanofi-Aventis Investigational Site Number 484008
city: Aguascalientes
country: Mexico
facility: Sanofi-Aventis Investigational Site Number 484013
city: Aguascalientes
country: Mexico
facility: Sanofi-Aventis Investigational Site Number 484016
city: Guadalajara
country: Mexico
facility: Sanofi-Aventis Investigational Site Number 484004
city: Guadalajara
country: Mexico
facility: Sanofi-Aventis Investigational Site Number 484007
city: Mexico Df
country: Mexico
facility: Sanofi-Aventis Investigational Site Number 484012
city: Monterrey
country: Mexico
facility: Sanofi-Aventis Investigational Site Number 484010
city: San Luis Potosi
country: Mexico
facility: Sanofi-Aventis Investigational Site Number 484011
city: San Luis Potosi
country: Mexico
facility: Sanofi-Aventis Investigational Site Number 484005
city: Veracruz
country: Mexico
facility: Sanofi-Aventis Investigational Site Number 484003
city: Marrakech
country: Morocco
facility: Sanofi-Aventis Investigational Site Number 504001
city: Meknes
country: Morocco
facility: Sanofi-Aventis Investigational Site Number 504002
city: Almelo
country: Netherlands
facility: Sanofi-Aventis Investigational Site Number 528012
city: Amsterdam
country: Netherlands
facility: Sanofi-Aventis Investigational Site Number 528030
city: Breda
country: Netherlands
facility: Sanofi-Aventis Investigational Site Number 528026
city: Delft
country: Netherlands
facility: Sanofi-Aventis Investigational Site Number 528009
city: Den Haag
country: Netherlands
facility: Sanofi-Aventis Investigational Site Number 528035
city: Ede
country: Netherlands
facility: Sanofi-Aventis Investigational Site Number 528027
city: Eindhoven
country: Netherlands
facility: Sanofi-Aventis Investigational Site Number 528006
city: Eindhoven
country: Netherlands
facility: Sanofi-Aventis Investigational Site Number 528017
city: Gouda
country: Netherlands
facility: Sanofi-Aventis Investigational Site Number 528016
city: Harderwijk
country: Netherlands
facility: Sanofi-Aventis Investigational Site Number 528007
city: Heerlen
country: Netherlands
facility: Sanofi-Aventis Investigational Site Number 528001
city: Heerlen
country: Netherlands
facility: Sanofi-Aventis Investigational Site Number 528024
city: Hengelo
country: Netherlands
facility: Sanofi-Aventis Investigational Site Number 528003
city: Hengelo
country: Netherlands
facility: Sanofi-Aventis Investigational Site Number 528010
city: Hoogeveen
country: Netherlands
facility: Sanofi-Aventis Investigational Site Number 528031
city: Hoorn
country: Netherlands
facility: Sanofi-Aventis Investigational Site Number 528019
city: Leeuwarden
country: Netherlands
facility: Sanofi-Aventis Investigational Site Number 528020
city: Nijmegen
country: Netherlands
facility: Sanofi-Aventis Investigational Site Number 528004
city: Rotterdam
country: Netherlands
facility: Sanofi-Aventis Investigational Site Number 528013
city: Sittard-Geleen
country: Netherlands
facility: Sanofi-Aventis Investigational Site Number 528022
city: Sneek
country: Netherlands
facility: Sanofi-Aventis Investigational Site Number 528002
city: Tilburg
country: Netherlands
facility: Sanofi-Aventis Investigational Site Number 528033
city: Venlo
country: Netherlands
facility: Sanofi-Aventis Investigational Site Number 528021
city: Zoetermeer
country: Netherlands
facility: Sanofi-Aventis Investigational Site Number 528005
city: Zwolle
country: Netherlands
facility: Sanofi-Aventis Investigational Site Number 528025
city: Christchurch
country: New Zealand
facility: Sanofi-Aventis Investigational Site Number 554003
city: Dunedin
country: New Zealand
facility: Sanofi-Aventis Investigational Site Number 554002
city: Nelson
country: New Zealand
facility: Sanofi-Aventis Investigational Site Number 554001
city: Bergen
country: Norway
facility: Sanofi-Aventis Investigational Site Number 578001
city: Flekkefjord
country: Norway
facility: Sanofi-Aventis Investigational Site Number 578006
city: Lørenskog
country: Norway
facility: Sanofi-Aventis Investigational Site Number 578005
city: Oslo
country: Norway
facility: Sanofi-Aventis Investigational Site Number 578004
city: Panama
country: Panama
facility: Sanofi-Aventis Investigational Site Number 591001
city: Panama
country: Panama
facility: Sanofi-Aventis Investigational Site Number 591002
city: Panama
country: Panama
facility: Sanofi-Aventis Investigational Site Number 591003
city: Lima
country: Peru
facility: Sanofi-Aventis Investigational Site Number 604004
city: Lima
country: Peru
facility: Sanofi-Aventis Investigational Site Number 604002
city: Lima
country: Peru
facility: Sanofi-Aventis Investigational Site Number 604001
city: Lima
country: Peru
facility: Sanofi-Aventis Investigational Site Number 604005
city: Lima
country: Peru
facility: Sanofi-Aventis Investigational Site Number 604003
city: Quezon City
country: Philippines
facility: Sanofi-Aventis Investigational Site Number 608001
city: Chojnice
country: Poland
facility: Sanofi-Aventis Investigational Site Number 616013
city: Gdansk
country: Poland
facility: Sanofi-Aventis Investigational Site Number 616011
city: Gdynia-Redlowo
country: Poland
facility: Sanofi-Aventis Investigational Site Number 616014
city: Katowice
country: Poland
facility: Sanofi-Aventis Investigational Site Number 616009
city: Lodz
country: Poland
facility: Sanofi-Aventis Investigational Site Number 616017
city: Lublin
country: Poland
facility: Sanofi-Aventis Investigational Site Number 616002
city: Ostrowiec Swietokrzyski
country: Poland
facility: Sanofi-Aventis Investigational Site Number 616012
city: Pulawy
country: Poland
facility: Sanofi-Aventis Investigational Site Number 616015
city: Torun
country: Poland
facility: Sanofi-Aventis Investigational Site Number 616007
city: Tychy
country: Poland
facility: Sanofi-Aventis Investigational Site Number 616006
city: Warszawa
country: Poland
facility: Sanofi-Aventis Investigational Site Number 616001
city: Warszawa
country: Poland
facility: Sanofi-Aventis Investigational Site Number 616010
city: Wroclaw
country: Poland
facility: Sanofi-Aventis Investigational Site Number 616008
city: Amadora
country: Portugal
facility: Sanofi-Aventis Investigational Site Number 620002
city: Braga
country: Portugal
facility: Sanofi-Aventis Investigational Site Number 620007
city: Coimbra
country: Portugal
facility: Sanofi-Aventis Investigational Site Number 620006
city: Setubal
country: Portugal
facility: Sanofi-Aventis Investigational Site Number 620008
city: San Juan
country: Puerto Rico
facility: Sanofi-Aventis Investigational Site Number 630001
city: Barnaul
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643033
city: Chelyabinsk
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643040
city: Chelyabinsk
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643050
city: Chelyabinsk
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643036
city: Ekaterinburg
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643031
city: Kemerovo
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643009
city: Kemerovo
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643042
city: Moscow
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643015
city: Moscow
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643032
city: Moscow
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643007
city: Moscow
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643020
city: Moscow
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643054
city: Moscow
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643052
city: Moscow
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643056
city: Moscow
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643025
city: Moscow
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643053
city: Moscow
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643028
city: Moscow
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643037
city: Moscow
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643001
city: Moscow
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643026
city: Moscow
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643039
city: Moscow
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643011
city: Moscow
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643034
city: Moscow
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643049
city: Moscow
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643030
city: Nizhny Novgorod
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643013
city: Nizniy Novgorod
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643041
city: Novosibirsk-117
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643048
city: Novosibirsk
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643051
city: Novosibirsk
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643044
city: Penza
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643045
city: Perm
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643023
city: Perm
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643006
city: Petrozavodsk
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643046
city: Rostov-Na-Donu
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643012
city: Ryazan
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643008
city: Saint-Petersburg
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643017
city: Saint-Petersburg
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643047
city: Samara
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643029
city: Saratov
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643004
city: Saratov
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643005
city: Saratov
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643003
city: St-Petersburg
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643022
city: St-Petersburg
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643038
city: St-Petersburg
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643016
city: St-Petersburg
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643018
city: St-Petersburg
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643010
city: St-Petersburg
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643027
city: St-Petersburg
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643002
city: Tomsk
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643024
city: Tomsk
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643035
city: Tyumen
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643021
city: Voronezh
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643043
city: Yaroslavl
country: Russian Federation
facility: Sanofi-Aventis Investigational Site Number 643019
city: Kosice
country: Slovakia
facility: Sanofi-Aventis Investigational Site Number 703003
city: Levice
country: Slovakia
facility: Sanofi-Aventis Investigational Site Number 703005
city: Nitra
country: Slovakia
facility: Sanofi-Aventis Investigational Site Number 703004
city: Poprad
country: Slovakia
facility: Sanofi-Aventis Investigational Site Number 703006
city: Trnava
country: Slovakia
facility: Sanofi-Aventis Investigational Site Number 703002
city: Amanzimtoti
country: South Africa
facility: Sanofi-Aventis Investigational Site Number 710013
city: Bloemfontein
country: South Africa
facility: Sanofi-Aventis Investigational Site Number 710011
city: Cape Town
country: South Africa
facility: Sanofi-Aventis Investigational Site Number 710007
city: Cape Town
country: South Africa
facility: Sanofi-Aventis Investigational Site Number 710017
city: Durban
country: South Africa
facility: Sanofi-Aventis Investigational Site Number 710001
city: Durban
country: South Africa
facility: Sanofi-Aventis Investigational Site Number 710012
city: Johannesburg
country: South Africa
facility: Sanofi-Aventis Investigational Site Number 710009
city: Port Elizabeth
country: South Africa
facility: Sanofi-Aventis Investigational Site Number 710016
city: Pretoria
country: South Africa
facility: Sanofi-Aventis Investigational Site Number 710020
city: Pretoria
country: South Africa
facility: Sanofi-Aventis Investigational Site Number 710003
city: Pretoria
country: South Africa
facility: Sanofi-Aventis Investigational Site Number 710002
city: Randburg
country: South Africa
facility: Sanofi-Aventis Investigational Site Number 710015
city: Scottburgh
country: South Africa
facility: Sanofi-Aventis Investigational Site Number 710014
city: Umhlanga Rocks
country: South Africa
facility: Sanofi-Aventis Investigational Site Number 710018
city: Barcelona
country: Spain
facility: Sanofi-Aventis Investigational Site Number 724003
city: Barcelona
country: Spain
facility: Sanofi-Aventis Investigational Site Number 724002
city: Madrid
country: Spain
facility: Sanofi-Aventis Investigational Site Number 724001
city: Santiago De Compostela
country: Spain
facility: Sanofi-Aventis Investigational Site Number 724005
city: Sevilla
country: Spain
facility: Sanofi-Aventis Investigational Site Number 724007
city: Göteborg
country: Sweden
facility: Sanofi-Aventis Investigational Site Number 752003
city: Göteborg
country: Sweden
facility: Sanofi-Aventis Investigational Site Number 752006
city: Malmo
country: Sweden
facility: Sanofi-Aventis Investigational Site Number 752007
city: Malmö
country: Sweden
facility: Sanofi-Aventis Investigational Site Number 752002
city: Ostersund
country: Sweden
facility: Sanofi-Aventis Investigational Site Number 752004
city: Stockolm
country: Sweden
facility: Sanofi-Aventis Investigational Site Number 752001
city: Kaohsiung
country: Taiwan
facility: Sanofi-Aventis Investigational Site Number 158003
city: Taichung
country: Taiwan
facility: Sanofi-Aventis Investigational Site Number 158002
city: Tainan Hsien
country: Taiwan
facility: Sanofi-Aventis Investigational Site Number 158004
city: Taipei
country: Taiwan
facility: Sanofi-Aventis Investigational Site Number 158001
city: Taipei
country: Taiwan
facility: Sanofi-Aventis Investigational Site Number 158005
city: Bangkok-Noi
country: Thailand
facility: Sanofi-Aventis Investigational Site Number 764002
city: Bangkok
country: Thailand
facility: Sanofi-Aventis Investigational Site Number 764001
city: Muang
country: Thailand
facility: Sanofi-Aventis Investigational Site Number 764003
city: Edirne
country: Turkey
facility: Sanofi-Aventis Investigational Site Number 792004
city: Edirne
country: Turkey
facility: Sanofi-Aventis Investigational Site Number 792005
city: Istanbul
country: Turkey
facility: Sanofi-Aventis Investigational Site Number 792002
city: Istanbul
country: Turkey
facility: Sanofi-Aventis Investigational Site Number 792001
city: Istanbul
country: Turkey
facility: Sanofi-Aventis Investigational Site Number 792003
city: Kocaeli
country: Turkey
facility: Sanofi-Aventis Investigational Site Number 792006
city: Kocaeli
country: Turkey
facility: Sanofi-Aventis Investigational Site Number 792007
city: Dnepropetrovsk
country: Ukraine
facility: Sanofi-Aventis Investigational Site Number 804013
city: Dnepropetrovsk
country: Ukraine
facility: Sanofi-Aventis Investigational Site Number 804015
city: Dnipropetrovsk
country: Ukraine
facility: Sanofi-Aventis Investigational Site Number 804005
city: Ivano-Frankivsk
country: Ukraine
facility: Sanofi-Aventis Investigational Site Number 804008
city: Kharkiv
country: Ukraine
facility: Sanofi-Aventis Investigational Site Number 804004
city: Kharkov
country: Ukraine
facility: Sanofi-Aventis Investigational Site Number 804002
city: Kharkov
country: Ukraine
facility: Sanofi-Aventis Investigational Site Number 804012
city: Kiev
country: Ukraine
facility: Sanofi-Aventis Investigational Site Number 804003
city: Lutsk
country: Ukraine
facility: Sanofi-Aventis Investigational Site Number 804007
city: Lutsk
country: Ukraine
facility: Sanofi-Aventis Investigational Site Number 804009
city: Odessa
country: Ukraine
facility: Sanofi-Aventis Investigational Site Number 804011
city: Ternopil
country: Ukraine
facility: Sanofi-Aventis Investigational Site Number 804010
city: Uzhgorod
country: Ukraine
facility: Sanofi-Aventis Investigational Site Number 804006
city: Zaporizhzhia
country: Ukraine
facility: Sanofi-Aventis Investigational Site Number 804014
city: Caracas
country: Venezuela
facility: Sanofi-Aventis Investigational Site Number 862001
city: Maracay
country: Venezuela
facility: Sanofi-Aventis Investigational Site Number 862002
Study officials:
affiliation: Sanofi
name: Clinical Sciences & Operations
role: STUDY_DIRECTOR
References:
citation: Buller HR, Halperin J, Hankey GJ, Pillion G, Prins MH, Raskob GE. Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study. J Thromb Haemost. 2014 Jun;12(6):824-30. doi: 10.1111/jth.12546.